Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.

With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

It plans to estimate the "comparative therapeutic impact" of the two drugs compared to their respective ... in patients with moderate to severe COPD. So far, attempts by the industry to strike ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This in-depth analysis shows that the Global Asthma and COPD Drugs Market, valued at ...

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

Although these products might confer significant advantages over the currently available treatments, there is still a huge unmet need for drugs that prevent the progression of COPD. Companies are ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

Many people with COPD have other conditions like diabetes or high cholesterol, too. Managing several conditions can be ...

A person can get a COPD inhaler through Medicare Part D or ... For Medicare, this usually applies to prescription drugs. People enrolled in Original Medicare (parts A and B) can add Medicare ...